Mitsubishi Estate Company,Limited

8802 TSE Real Estate Real Estate
TSE Prime
¥3,910.00
-8.56%
Delayed · cached 15 min

Fair value analysis

8802
Mitsubishi Estate Company,Limited
Real Estate›Real Estate
¥3,683.00
Close used for this calculation
¥2,986.63Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
38/100
Profitability15/25
Returns7/25
Balance Sheet5/25
Efficiency11/25
Growth6/25
Average
Quality radar
38Prof.15/25Ret.7/25Eff.11/25B.Sht5/25Growth6/25
⚖️ Consensus Fair Value / Intrinsic Value (10 models)
¥2,986.63
▼ 18.9% vs the close used
Range: ¥1,395.08 – ¥3,636.00
● OVERVALUED
¥2,986.63 fair value
🎯 Price Target Range & 52W Position
Bear¥1,395.08Fair Value¥2,986.63Bull¥3,636.00
FairNow
52W Low ¥3,204.0052W High ¥5,308.00

52W range measured from stored price history, not estimated.

📈 Valuation Summary
Trading Above Fair Value
Mitsubishi Estate Company,Limited closed at ¥3,683.00 — 23.3% above the consensus fair value of ¥2,986.63 drawn from 9 valuation models. P/E of 21.5x against the sector multiple the P/E model uses.
All 10 Valuation Models
DCF Valuation
¥3,608.55
-2.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
¥3,021.67
-18.0%
√(22.5 × EPS × BVPS)
EPS=181.8, BVPS=2232.12 · outside Graham range (P/E 20.3, P/B 1.7) — asset-light, treat as a rough floor
P/E Fair Value
¥3,636.00
-1.3%
EPS × 20x (sector P/E)
EPS=181.8, Sector P/E=20x
Peter Lynch (PEG)
¥1,714.37
-53.5%
EPS × Growth% (PEG = 1 is fair)
EPS=181.8, g=9.4%
EV/EBITDA
¥2,582.22
-29.9%
(EBITDA × 14.7x − Net Debt) ÷ Shares
EBITDA=437.76B
Dividend Discount (DDM)
¥2,486.03
-32.5%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=46.04, r=10%, g=8%
Book Value (P/B)
¥1,395.08
-62.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=2232.12, ROE=8.5%, g=6%, r=10%
Reverse DCF
¥3,683.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 7.3% | Historical: 9.4%
Margin of Safety
¥2,566.56
-30.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=3422.07, MoS=25%
📊 Historical P/E Band

10-year P/E range — where does today's valuation sit historically?

Value zoneFair zonePremium zoneCurrent P/E
Sector 20.0xNow 21.5x
0x5x10x15x20x25x30x35x40x45x50x
Value ZoneFair ZonePremium
Fair Zone — around sector rangeCurrent P/E: 21.5xSector P/E: 20.0x+7.6% vs sector avg
Key Metrics
ROE
8.50%
Benchmark: > 15%
✗ Below benchmark
ROCE
4.46%
Benchmark: > 15%
✗ Below benchmark
PAT Margin
12.74%
Benchmark: > 10%
✓ Good
D/E Ratio
1.98x
Benchmark: < 0.5x
✗ Below benchmark
Current Ratio
1.93x
Benchmark: >= 1.2x
✓ Good
EPS (TTM)
¥181.80
Benchmark: Higher is better
P/E Ratio
21.51x
Benchmark: < 25x
✓ Good
ICR
5.98x
Benchmark: > 3x
✓ Good

Computed on September 17, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Formula Guide

🪮 Financial DNA Score — How it's Calculated

Scored 0–100 across four equal pillars (0–25 each). Higher = stronger business quality.

Profitability (0–25)
PAT Margin + EPS Growth
  • PAT >20% → 15pts | >10% → 10pts | >5% → 5pts
  • EPS growth >15% → 10pts | >8% → 7pts | >0% → 4pts
Returns (0–25)
ROE + ROCE + PE Sanity
  • ROE >20% → 10pts | >15% → 7pts | >10% → 4pts
  • ROCE >20% → 8pts | >15% → 5pts
  • PE <25x → 7pts | <35x → 5pts
Balance Sheet (0–25)
D/E + Current Ratio + Cash PAT
  • D/E=0 → 10pts | <0.5x → 7pts | <1x → 4pts
  • CR >1.5x → 8pts | >1.2x → 5pts
  • Cash PAT >1x → 7pts | >0.7x → 4pts
Efficiency (0–25)
Justified P/B + Dividend + Earnings Yield
  • P/B < justified P/B → 10pts
  • Div Yield >2% → 8pts | >1% → 5pts
  • Earnings Yield >5% → 7pts | >3% → 4pts
TCS example: ROE 51.8% (10) + ROCE 63% (8) + PE 15.6x (7) + PAT 18.5% (10) + D/E 0 (10) + CR 1.5x (8) + Div 1.8% (5) = 73/100 Strong
⚖️ Consensus Fair Value — How it's Calculated

Uses a sector-weighted composite — not a simple average — to prevent outlier models from distorting results.

Consensus = Σ(Model Value × Weight) ÷ Σ(Weights)
IT / Pharma / FMCG
  • DCF — 50%
  • P/E Fair Value — 30%
  • Peter Lynch PEG — 20%
Banks / NBFCs
  • Book Value (RIM) — 50%
  • P/E Fair Value — 30%
  • DDM — 20%
Cyclical / Metals / Auto
  • EV/EBITDA — 50%
  • DCF — 30%
  • P/E Fair Value — 20%
Conglomerate / General
  • DCF — 40%
  • P/E Fair Value — 35%
  • EV/EBITDA — 25%
⚠️ The Graham Number is shown for all stocks; for asset-light companies (ROE >40%, or ROE >20% with P/B >6) it reads low and is captioned as a rough floor. The Graham Formula is still excluded for those and for financial companies.
📐 10 Valuation Models — Formulas & Sector Guide
ModelFormulaBest ForAvoid When
1. DCFΣ[FCF×(1+g)ⁿ/(1+r)ⁿ] + TV/(1+r)¹⁰IT, Pharma, FMCGBanks, cyclicals, negative FCF
2. Graham Number√(22.5 × EPS × BVPS)Asset-heavy value stocksIT, FMCG (ROE>40%)
3. Graham FormulaEPS × (8.5 + 2g) × 6.5 ÷ Bond YieldINR stocks, moderate growthAsset-light, US stocks
4. P/E Fair ValueEPS × Sector PE MultipleUniversalLoss-making companies
5. Peter Lynch PEGEPS × Growth% (PEG=1 is fair)Growth companiesLow-growth, cyclicals
6. EV/EBITDA(EBITDA × Multiple − Net Debt) ÷ SharesMetals, cement, autoBanks, FMCG, asset-light
7. DDMD₁ ÷ (r − g), D₁ = D₀×(1+g)Banks, utilities, mature payersNon-dividend, growth stocks
8. Justified P/B (RIM)BVPS × (ROE−g) ÷ (r−g)Banks, NBFCs, insuranceIT, FMCG asset-light
9. Reverse DCFSolve g: Price = Σ[EPS/(1+r)ⁿ] + TVAll stocks (diagnostic)—
10. Margin of SafetyAvg(DCF, Graham, P/E) × 75%Conservative investorsHigh-growth stocks
SectorPrimary (50%)Secondary (30%)Third (20%)Sector PE
IT / SoftwareDCFP/EPeter Lynch25x
PharmaDCFP/EPeter Lynch28x
FMCG / ConsumerDCFP/EGraham Formula30x
BanksBook Value RIMP/EDDM18x
NBFCBook Value RIMP/EEV/EBITDA25x
Insurance / AMCP/EBook ValueDCF40x / 30x
AutoEV/EBITDADCFP/E22x
Metals / SteelEV/EBITDABook ValueDCF8x
Utilities / PowerEV/EBITDADCFP/E18x
Real EstateBook Value (NAV)DCFP/E25x
ConglomerateDCFP/EEV/EBITDA20x
💧 Liquidity Stack — Formulas Explained

Three progressive ratios — each more conservative. Together they reveal the quality of short-term solvency.

Current Ratio
Current Assets ÷ Current Liabilities
  • Includes: Cash + Inventory + Receivables
  • Benchmark: >1.2x ✓ <1.0x ✗
Quick Ratio
(Current Assets − Inventory) ÷ Current Liabilities
  • Excludes inventory (may not liquidate quickly)
  • Benchmark: >1.0x ✓
Cash Ratio (Strictest)
Cash & Equivalents ÷ Current Liabilities
  • Only cash on hand — most conservative
  • Benchmark: >0.2x ✓
Stack Gap Reading
Gap = Current − Quick
  • Gap <0.2 → Low inventory dependency ✓
  • Gap >0.5 → Liquidity depends on selling stock
📏 Key Metrics — Benchmarks Explained
MetricFormulaBenchmarkWhat it Measures
ROENet Profit ÷ Shareholders' Equity>15%Efficiency of equity in generating profit
ROCEEBIT ÷ Capital Employed>15%Returns on all capital (equity + debt)
PAT MarginNet Profit ÷ Revenue>10%Profit per 100 of revenue
D/E RatioTotal Debt ÷ Shareholders' Equity<0.5xFinancial leverage — lower is safer
Current RatioCurrent Assets ÷ Current Liabilities>1.2xShort-term solvency
ICREBIT ÷ Interest Expense>3xCan earnings cover interest?
Cash PATOperating Cash Flow ÷ Net Profit>0.9x<0.9x suggests accounting inflation of profits
DSCR(Net Income + D&A) ÷ Debt Service>1.5xCan the company service its debt?
📊 Live Reference Output — 8802

This stock's full breakdown — DNA score, consensus fair value and every model — is in the Overview & summary and 10 valuation models tabs.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.